Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
42,106,165
-
Share change
-
+6,136,650
-
Total reported value
-
$212,715,890
-
Put/Call ratio
-
170%
-
Price per share
-
$5.05
-
Number of holders
-
161
-
Value change
-
+$30,515,138
-
Number of buys
-
86
-
Number of sells
-
63
Institutional Holders of Humacyte, Inc. - COM (HUMA) as of Q4 2024
As of 31 Dec 2024,
Humacyte, Inc. - COM (HUMA) was held by
161 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,106,165 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, Woodline Partners LP, GEODE CAPITAL MANAGEMENT, LLC, CenterBook Partners LP, UBS Group AG, TWO SIGMA INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC, and NORTHERN TRUST CORP.
This page lists
161
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.